|
""Oncorequisite"" Genes in MYC-mediated Transformation
|
5R00CA134743-05
|
$234,037
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
(PQB2) Ontogeny of the tumor-immune interplay in a developmental malignancy
|
1R21CA189990-01
|
$193,575
|
MURRAY, PETER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-38S1
|
$74,997
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-38
|
$7,449,701
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Acidic Phospholipid-Selective Treatment for Neuroblastoma
|
5R01CA158372-04
|
$315,542
|
QI, XIAOYANG
|
UNIVERSITY OF CINCINNATI
|
|
Bay Area Tumor Institute CCOP
|
3U10CA045461-24S1
|
$81,028
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S1
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S3
|
$48,834
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S4
|
$149,801
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-08
|
$2,746,741
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-12S2
|
$129,070
|
ROBERTSON, JOHN
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Berberine downregulates MDM2 by interaction with DAXX in cancer cells
|
5R01CA143107-05
|
$65,349
|
ZHOU, MUXIANG
|
EMORY UNIVERSITY
|
|
BIOINFORMATICS: SYSTEMS BIOLOGY OF PEDIATRIC CANCERS
|
ZIA BC 011002
|
$524,843
|
Khan, Javed
|
CCR (NCI)
|
|
Biology and Therapy of High Risk Neuroblastoma
|
5P01CA081403-15
|
$1,925,523
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$358,240
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
2P30CA013696-40
|
$3,596,904
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S1
|
$125,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S2
|
$50,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S3
|
$320,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-40S4
|
$75,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
2P30CA008748-48
|
$12,352,942
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Cancer Center Support Grant
|
3P30CA008748-48S1
|
$74,197
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Cancer Center Support Grant
|
3P30CA008748-48S2
|
$115,999
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Cancer Center Support Grant
|
3P30CA082103-16S2
|
$49,999
|
CARROLL, PETER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-16S3
|
$74,999
|
CARROLL, PETER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA082103-16
|
$7,049,997
|
CARROLL, PETER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-32S1
|
$75,000
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA022453-32
|
$2,459,346
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S5
|
$10,116,159
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S6
|
$75,000
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S7
|
$122,667
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
2P30CA021765-35
|
$5,765,603
|
GILBERTSON, RICHARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
3P30CA021765-35S1
|
$75,000
|
GILBERTSON, RICHARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Specific Sensitivity to Suppression of Spliceosome Components
|
1F32CA180653-01A1
|
$53,282
|
PAOLELLA, BRENTON
|
DANA-FARBER CANCER INST
|
|
Center for Environment-Mediated Drug Resistance in Pediatric Cancer
|
5U54CA163117-04
|
$473,452
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-20
|
$4,071,218
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Clinical Development of HU14.18-IL2 Targeted Therapy
|
5R01CA032685-30
|
$302,121
|
SONDEL, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
ZIA SC 010354
|
$483,032
|
Widemann, Brigitte
|
CCR (NCI)
|
|
COG NCTN Network Group Operations Center
|
1U10CA180886-01
|
$26,616,497
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S1
|
$79,593
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S2
|
$208,457
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S3
|
$229,232
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S4
|
$1,163,256
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S5
|
$1,543,656
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S6
|
$265,465
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S7
|
$3,000,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
1U10CA180884-01
|
$400,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Columbia University Medical Center Minority-Based Community Clinical Oncology Pro
|
3U10CA167791-02S1
|
$73,416
|
KELLY, KARA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Combination immunotherapy for neuroblastoma: model of innate tumor immunity
|
5R01CA164365-03
|
$354,947
|
HSU, KATHARINE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Combination therapy to inhibit neuroblastoma growth
|
5R01CA147792-05
|
$344,838
|
GONDI, CHRISTOPHER
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|